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Abstract The aim of this study was to investigate the
possible association of a distinct combination of poly-
morphisms in the interleukin (IL)-1 gene cluster on gingival
bleeding tendency in young adult Arabs with plaque-
induced gingivitis. Fifty otherwise healthy, nonsmoking
volunteers, 19–28 years of age, participated. Clinical
examinations included periodontal probing depth, bleeding
on probing, and plaque index. Probing was done with a
pressure-controlled probe at about 1.27 MPa. Examinations
were repeated after 2 and 4 weeks. Polymorphisms in the
IL-1 gene cluster were assessed using a reverse hybridiza-
tion assay. A subject carrying alleles 2 at IL-1A−889 and IL-
1B+3954 was designated genotype-positive. Twenty-six sub-
jects were genotype-positive (52%). A repeated measures
two-level (occasion, subject) model of the proportion of sites
bleeding on probing, which was adjusted for gender,
average plaque index, probing depth, and calculus, revealed
a significantly lower proportion of bleeding sites in
genotype-positive subjects (estimate −0.050, standard error
0.025, p<0.05). Biserial correlations of bleeding proportions
were high (0.71–0.78), confirming the steady-state plaque
environment. It was concluded that inflammatory responses
to dental plaque were considerably dampened in genotype-
positive, nonsmoking young adults of Arabic heritage.
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Introduction
Possible factors that may modulate the inflammatory
response in gingiva to bacterial plaque residing on the
adjacent tooth surface have recently been reviewed in some
detail [33]. Considerable differences in clinical expression
of gingivitis [28] may be explained by both intrinsic and
extrinsic determinants. Among the former, genetic poly-
morphisms have attracted considerable attention in the
study of inflammatory responses [16]. A distinct combina-
tion of alleles 2 of interleukin (IL)-1A at locus −889 and IL-
1B at locus +3954 seems to be associated with more severe
periodontitis in certain ethnicities [1, 17]. This composite
genotype was associated with higher proportions of
gingival units bleeding upon probing in nonsmoking treated
periodontitis patients during supportive care [20]. In recent
gingivitis experiments, however, these polymorphisms
could not be related to an altered development of gingival
inflammation [14, 30]. The aim of the present study was to
assess the possible association of this particular genotype
on plaque-associated gingivitis, a precursor of any destruc-
tive periodontitis, in a steady-state plaque environment.
Because smoking has been shown to dampen the inflam-




To be enrolled, subjects had to meet the following inclusion
criteria: (1) Arabian descent, (2) minimum age of 18 and
maximum age of 28 years, (3) mild or moderate plaque-
induced gingival disease as defined by slight edema and
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redness in certain areas, and (4) minimal amounts of
supragingival calculus. The following exclusion criteria
applied: (1) any indication for antibiotic prophylaxis, (2)
pregnancy or lactation, (3) any long-term medication with a
possible effect on gingival inflammation, (4) any non-plaque-
induced gingival disease, (5) destructive periodontal disease
with a possible exception of localized gingival recession, (6)
extensive tooth restoration or tooth replacement, (7) any
presently undertaken orthodontic treatment, and (8) smoking.
Fifty volunteers were eligible and invited to participate. The
34 female and 16 male volunteers had a mean (± standard
deviation) age of 22.4±1.6 years and were systemically
healthy. They had a minimum of 23 erupted teeth (mean
29.2±2.5), and, with a few exceptions (first molars due to
caries), teeth had been extracted for surgical (third molars) or
orthodontic reasons (premolars). After written and oral
briefing on the study’s objectives, procedures, risks, and
benefits, volunteers gave their written consent for participa-
tion. The study design had been reviewed and approved by
Kuwait University Faculty of Dentistry’s Ethical Committee
as conforming to Ethical Principles for Medical Research
Involving Human Subjects according to the World Medical
Association Declaration of Helsinki (http://www.wma.net/e/
policy/b3.htm as accessed October 12, 2006). Because time
since last oral prophylaxis varied among volunteers, 1 week
prior to the commencement of the clinical trial, any supra-
gingival was removed and tooth surfaces were polished.
Clinical examination
One week after supragingival scaling and polishing,
periodontal conditions were recorded at six sites of every
tooth present. Periodontal probing depth and clinical
attachment level were measured with a pressure-calibrated
probe (ClickProbe 1395, KerrHawe, Bioggio, Switzerland)
at about 1.27 MPa to the nearest millimeter. Gingival
bleeding on probing was assessed after about 20 s.
Reliability of gingival bleeding after different time intervals
had been assessed in a separate population [27]. Presence of
calculus was recorded. Supragingival plaque was disclosed
with a plaque revelator (D&C Red-28, Sultan Chemists,
Englewood, NJ, USA) and its amount estimated using
criteria of the plaque index (scores 0–3) system [32].
Whereas toothpaste, tooth brushing frequency, and use of
dental floss were recorded in a questionnaire, no attempt was
made to improve the oral hygiene of the volunteers. Instead,
they were advised not to alter their oral hygiene habits.
Periodontal examinations were repeated after 2 and 4 weeks.
Interleukin-1 genotype
After collecting all clinical data, a swab sample of cheek
mucosa was obtained from each volunteer. Samples were
immediately sent to a commercial laboratory (Hain Life-
science, Nehren, Germany) by courier mail. The samples
were processed using a commercial assay (GenoType®,
PST®, Hain Lifescience). DNAwas extracted and sequences
of the IL-1 gene cluster were amplified by polymerase chain
reaction using HotStar Taq polymerase (Qiagen, Hilden,
Germany) and a final MgCl2 concentration of 2.5 mM.
Subsequently, polymorphisms at locus −889 of the IL-1A
gene and at locus +3954 of IL-1B gene were investigated
by reverse hybridization of the generated amplicons to
specific probes immobilized on membrane strips [3]. To be
positive for the composite IL-1 genotype, a subject required
at least 1 copy of allele 2 at both loci [17].
Statistical analysis
Primary outcome variables of mean periodontal probing
depth, clinical attachment level, plaque index, and propor-
tion of sites bleeding on probing and covered by calculus
are given as mean ± standard deviation. Conventional
repeated measures analyses of variance were applied to test
the (null) hypotheses of stable periodontal conditions
(percent of sites bleeding on probing, average plaque index,
average periodontal probing parameters, percent of sites
covered by calculus) during the 4-week experiment and no
influence of the IL-1 genotype on outcomes. A repeated-
measures, two-level (occasion, subject) model was then
applied to assess the effect of the IL-1 genotype on the
percentage of sites bleeding on probing in a steady state
plaque environment [12] with covariates gender and, at
each examination, average periodontal probing depth,
plaque index, and calculus proportion. Because of sparseness
of observations, loss of attachment was not considered.
Covariates were entered after centering [18]. There is no
level 1 (occasion) variation, and the proportion of sites
bleeding on probing was allowed to vary among subjects
(level 2). Thus, biserial correlations of bleeding proportions
between subsequent occasions were calculated according to
the variance/covariance matrix [12]. Special software was
used (MLwiN 2.0, Centre for Multilevel Modeling, Bristol
University, Bristol, UK).
Results
Allelic and composite IL-1 genotype distribution is shown
in Table 1. In total, 26 of 50 volunteers (52%, 95%
confidence interval 37%; 67%) had at least one copy of
allele 2 at both loci IL-1A−889 and IL-1B+3954, i.e., they
were diagnosed as IL-1-genotype-positive. No differences
between males and females were seen. Pearson’s χ2 test
revealed no deviation of genotype frequencies from Hardy–
Weinberg expectations, confirming random mating (Table 1).
298 Clin Oral Invest (2007) 11:297–302
Clinical periodontal conditions of the study population
are presented in Table 2. Mean periodontal probing depth
slightly decreased from about 1.8 to 1.7 mm (p<0.01).
Differences between genotype-negative and -positive sub-
jects were not significant. Any loss of clinical attachment
was due to few facial areas with gingival recession with no
difference between examinations or groups. The percent of
sites bleeding on probing decreased during the study from
21 to 18% (p<0.01). Genotype-positive subjects had
significantly fewer bleeding sites (p<0.05). This is further
illustrated in quantile plots (Fig. 1) indicating distributions
of proportions of sites bleeding on probing in genotype-
positive and -negative subjects. In contrast, plaque scores
were stable throughout the study with a mean plaque index
of about 1.2 and no significant differences between groups.
The mean percent of sites covered by calculus significantly
increased from 3 to 6% (p<0.001), but differences between
groups were not significant.
To further explore the association of the IL-1 genotype
with gingival bleeding in gingivitis, the proportion of sites
bleeding on probing was modeled in a repeated-measures,
two-level model, with occasion as the lowest level. The
model was adjusted for gender and, at each occasion,
average periodontal probing depth, mean plaque index, and
calculus proportion. In this model, the IL-1 genotype
remained significant (p<0.05), whereas all other covariates
did not significantly influence bleeding on probing propor-
tions (p>0.1). Thus, in genotype-positive subjects of the
same gender, with the same mean plaque index, amount of
calculus, and mean periodontal probing depth, a signifi-
cantly lower proportion of sites bled after probing (estimate
−0.050, standard error 0.025). Biserial correlations of
bleeding proportions at subsequent examinations were high
(0.71–0.78), indicating stability of average bleeding ten-
dency in a steady-state plaque environment.
Discussion
In this study, presence of a composite genotype based on
polymorphisms in the IL-1A and IL-1B genes was signif-
icantly associated with decreased bleeding tendency of
gingiva in young adult nonsmoking Arabs with plaque-
induced gingivitis. This observation was made independent
of the amount of supragingival plaque, percent of sites
covered by calculus, or mean periodontal probing depth.
During the menstrual cycle, subtle changes in gingival
inflammation independent of the amount of plaque have
recently been demonstrated [23], which might lead to an
increased bleeding tendency. The two-level model did not
reveal, however, a gender effect on bleeding tendency,
although the majority of volunteers here (68%) were
female.
Polymorphisms in genes encoding proinflammatory
cytokines have been shown to be associated with systemic
Table 2 Clinical periodontal conditions in genotype-negative and -positive subjects during the experiment
IL-1 genotype (−) IL−1 genotype (+)
Baseline 2 weeks 4 weeks Baseline 2 weeks 4 weeks
PPD/mm 1.86±0.26 1.80±0.24 1.75±0.24 1.73±0.24 1.71±0.24 1.71±0.21
CAL/mm 0.01±0.01 0.00±0.01 0.00±0.01 0.01±0.04 0.01±0.01 0.01±0.01
% BOP 24.1±12.9 21.6±11.1 21.9±13.8 18.6±8.7 16.0±9.0 14.6±7.6
PLI (0–3) 1.24±0.42 1.26±0.39 1.23±0.42 1.11±0.37 1.04±0.37 1.16±0.42
% CALC 2.6±2.9 5.7±4.8 7.5±8.9 3.2±4.1 4.0±3.8 4.8±4.3
Mean ± standard deviation. Data in bold are significantly lower in genotype-positive than in genotype-negative subjects at p<0.05 (repeated-
measures ANOVA)
PPD = probing pocket depth, CAL = clinical attachment level, BOP = bleeding on probing, PLI = plaque index, CALC = calculus
Table 1 Allele and composite genotype distribution (% in parenthe-
sis) of IL-1A−889 and IL-1B+3954 polymorphisms in male and female
subjects
Male Female Total Expected
IL-1A−889
1.1 6 (37.5) 14 (41.2) 20 (40.0) 21.1
1.2 8 (50.0) 17 (50.0) 25 (50.0) 22.8
2.2 2 (12.5) 3 (8.8) 5 (10.0) 6.1
χ22ð Þ ¼ 0:184,
p=0.912
χ21ð Þ ¼ 0:489,
p=0.484a
IL-1B+3954
1.1 8 (50.0) 16 (47.1) 24 (48.0) 23.1
1.2 6 (37.5) 14 (41.2) 20 (40.0) 21.8
2.2 2 (12.5) 4 (11.8) 6 (12.0) 5.1
χ22ð Þ ¼ 0:061,
p=0.970
χ21ð Þ ¼ 0:326,
p=0.568a
IL-1A−889 *2/IL-1B+3954 *2
8 (50.0) 18 (52.9) 26 (52.0)
χ22ð Þ ¼ 0:038,
p=0.846
Expected numbers according to the Hardy–Weinberg principle are also
given
a No deviation from Hardy–Weinberg equilibrium
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inflammation [6, 15, 21]. Here, we examined a composite
IL-1 genotype that has been related in several studies to
more severe destructive periodontal disease [1, 17, 19, 24].
Whereas another group could not find an association in
nonsmoking adults [25], they later reported that the IL-1
genotype seems to be a strong effect modifier of the effect
of smoking on periodontal structures [26]. Smoking is
generally regarded the most important risk factor for
destructive periodontal disease. About 50% of periodontitis
in the USA may be attributed to the deleterious effects of
smoking [34]. Interestingly, inflammatory responses in the
gingiva were also found to be significantly suppressed [4,
9, 13]. In particular, in experiments where plaque was
allowed to accumulate [5, 7, 11, 22], smoking led to a
delayed and dampened gingival reaction. The present study
used, for the first time, the steady-state plaque environment
for the study of a possible intrinsic (genetic) influence on
the association between plaque and gingival inflammation.
That IL-1 genotype-positive subjects would consistently
present with lower proportions of sites bleeding after
probing was not expected. Once periodontitis is present,
IL-1 genotype-positive patients have higher levels of
proinflammatory cytokines in gingival crevice fluid and
gingival tissues than their genotype-negative counterparts
[10]. In a cross-sectional multiple regression analysis
adjusted for the percent of tooth surfaces covered by visible
plaque, IL-1 genotype-positive, treated periodontitis
patients under maintenance care had a higher mean
proportion of sites bleeding on probing, about 3% points
[20]. The model explained only 11% of the variation in
overall bleeding tendency. Genotype-positive patients had
more residual periodontal pockets (mean 3.3±5.2) than
genotype-negative patients (2.7±3.2). Age and smoking as
possible confounders were not included in the model. This
might explain in part the discrepancy with our present data
in young adult nonsmokers without periodontal pockets. In
more recent plaque accumulation experiments, being a high
or low responder with regard to gingival inflammation was
not related to polymorphisms in the IL-1 gene cluster, while
other polymorphisms in the IL-1 gene cluster were involved
[30]. No difference in the development of experimental
gingivitis in IL-1 genotype-positives was observed by
Jepsen et al. [14]. It should be kept in mind, however, that
gingivitis might be better described in a steady-state plaque
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Fig. 1 Quantile plots illustrat-
ing cumulative distributions
of proportions of sites bleeding
on probing in IL-1 genotype
positive and negative subjects
at examinations 1 (a), 2 (b),
and 3 (c)
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environment where distribution of supragingival plaque
within the dentition is well defined, in particular, consistent
[29]. Recently, clinical conditions and cytokine profiles in
gingival exudate in a gingivitis experiment have been
compared with those in persistent gingivitis in a steady state
[8]. IL-1β concentrations were higher and IL-8 concentra-
tions lower after 4 weeks of experimental gingivitis as
compared to local concentrations in subjects with persistent
gingivitis. It was concluded that chronic gingivitis might
reflect a stage of a down-regulated proinflammatory
response [8] that might be further modulated by the specific
IL-1 genotype. Although a dampened inflammatory re-
sponse to dental plaque may in fact lead to more
periodontal destruction in heavy smokers, the analogy with
the present result of lower bleeding tendency in IL-1
genotype-positive young adult Arabs with plaque-induced
gingivitis has to be regarded speculatively because other
pathomechanisms are certainly involved. Whether the IL-1
genotype is actually related to the development of more
severe periodontitis in this Arab population needs to be
further explored in future studies.
The high prevalence of the composite genotype in this
Arabic population is notable. In fact, differences in
prevalence have been described in the past. For example,
prevalence seems to be about 36% in populations with a
Northern European heritage [25], whereas in a Chinese
population, this genotype was hardly detected [2]. The 52%
of the present study found in healthy young adults with
gingivitis may be the highest prevalence so far reported. In
further studies, the effect of the IL-1 genotype on
periodontal destruction in this Arabic population has to be
addressed.
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